Correction: Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform
Format: | Article |
---|---|
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118980/?tool=EBI |
Similar Items
-
Novel application of anti‐human Fc nanobody for screening high‐producing CHO cells for monoclonal antibody
by: Di Zhu, et al.
Published: (2022-10-01) -
Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody.
by: Veronika Chromikova, et al.
Published: (2017-01-01) -
Screening Naturally Occurring Phenolic Antioxidants for Their Suitability as Additives to CHO Cell Culture Media Used to Produce Monoclonal Antibodies
by: Luis Toronjo-Urquiza, et al.
Published: (2019-06-01) -
Using simple models to describe the kinetics of growth, glucose consumption, and monoclonal antibody formation in naive and infliximab producer CHO cells
by: López-Meza, Julián, et al.
Published: (2016) -
Strategy for Developing a Stable CHO Cell Line that Produces Large Titers of Trastuzumab Antibody
by: Hafsa Boulenouar, et al.
Published: (2023-11-01)